Allergen Research

PharmaceuticalsSeries AMenlo Park, USallergenresearch.com

Latest round

Series A

Last raised

Nov 2013

Total raised

$17M

Investors

1

About Allergen Research

Allergen Research Corp.Founded in 2011, Allergen Research Corp. operates from Menlo Park, US, focusing on offering its domain name to entities involved in allergen research.com primarily offers a domain name for sale, serving as a digital asset for businesses and individuals in the allergen research sector.Allergen Research Corp. Plans include targeting new geographic regions for potential buyers looking to enhance their online presence in allergen research. Specific new products or services are not outlined at this time.

Who invested in Allergen Research

1 investor across 1 round

See all investors in Allergen Research

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Nov 21, 2013

    Amount

    $17M

    Investors

    Locked

Questions about Allergen Research

Who invested in Allergen Research?

Allergen Research has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Allergen Research raised?

Allergen Research has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Allergen Research last raise money?

Allergen Research's most recent round on record is a Series A, in Nov 2013.

What does Allergen Research do?

Allergen Research is a pharmaceuticals company.

Where is Allergen Research headquartered?

Allergen Research is headquartered in Menlo Park, US.

Which VCs invest in companies like Allergen Research?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Allergen Research's stage. Their profiles are linked below.

Raising like Allergen Research? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.